Mission
Help healthcare professionals review complex information with greater clarity, without taking decisions away from those who hold clinical responsibility.
The company
Vieira Gonçalves — Saúde e Inovação, Lda.
A Portuguese healthcare AI product company, incorporated in 2026 and based in Braga. Early-stage, pre-revenue and founder-funded.
- 27 June 2026
- Incorporated
- Braga, Portugal
- Headquarters
- Early-stage · Pre-revenue
- Stage
- Healthcare AI and clinical software
- Focus
Who we are
A Portuguese healthcare AI product company.
Vieira Gonçalves — Saúde e Inovação, Lda was incorporated on 27 June 2026 and is based in Braga. We develop accountable software for complex healthcare workflows.
The company combines clinical perspective, product strategy and applied engineering. SICC is the lead product; Morpheus remains in research and development.
We build for evidence, human oversight and traceability, with disciplined validation before any expansion in use.
Mission · Vision · Values
What guides every product decision.
A clear mission, a European vision and principles suited to the responsibility of clinical software.
Vision
Make governed, evidence-linked clinical AI a dependable part of healthcare workflows across Europe.
Values
Scientific rigour. Clinical responsibility. Clarity. Privacy by design. Disciplined validation.
Goals
Prepare SICC for institutional evaluation and develop Morpheus as investigational software, with progress gated on evidence.
How we operate
A product-led company.
VGSI is a product-led healthcare technology company. We develop our own software platforms and prepare them for controlled institutional evaluation, integration and potential subscription commercialisation. Clinical experience informs product design; VGSI is not an IT consultancy or custom-development agency.
Founders
Founders with paths that complement each other.
Care experience, product strategy and engineering applied to a shared purpose.
Vieira Gonçalves — Saúde e Inovação, Lda.A Portuguese healthcare AI product company, incorporated in 2026 and based in Braga. Early-stage, pre-revenue and founder-funded.
Ana Luísa Vieira
Co-founder · Medicine, clinical governance and product safety
Specialist in Pulmonology with Ordem dos Médicos competence in Sleep Medicine and European certifications in Respiratory and Sleep Medicine.
José Gonçalves
Co-founder · Strategy, product and technology
More than 15 years across software development, data systems and product creation, including invited teaching and technology ventures before VGSI.
Governance and trust
In healthcare, an answer without context is not enough.
Clinical software should show where each suggestion came from, preserve human judgement and leave a clear record of the process.
Cloud development, institutional deployment
VGSI plans to use NVIDIA-accelerated computing on AWS for model development, evaluation and optimisation. Institutional deployment may use a local or dedicated-cloud profile; the data boundary, permitted traffic and external services will be agreed with each institution.
Visible evidence
Every suggestion points back to the clinical context supporting it.
Human oversight
The professional confirms, corrects or rejects before any final decision.
Traceability
Suggestions, changes and approvals remain documented.
Controlled deployment
Models are evaluated before any expansion in use.
Technology ecosystem
Programs we take part in.
VGSI is a member of NVIDIA Inception and AWS Activate. These programs provide access to technical resources, cloud infrastructure support and startup ecosystem opportunities as we validate and scale our healthcare AI products.
- Member of NVIDIA Inception
- AWS Activate member
Program membership does not imply investment, sponsorship, endorsement or a commercial relationship.
Talk to us
Let’s evaluate where accountable clinical AI can add value.
We welcome conversations with healthcare institutions, clinical coding teams, researchers, technology collaborators and investors.
Evaluate SICC
For healthcare organisations interested in a controlled evaluation of SICC.
Send a messageTechnology and research collaboration
For research, clinical or technology teams.
Send a messageInvestors
For investors following applied healthcare AI.
See the investor pageGeneral contact
For anything else.
Send a message